These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 12957087)

  • 1. Chemotherapy dose and schedule in adjuvant treatment of breast cancer: phoenix, turkey, or dodo?
    Crown J
    Lancet; 2003 Aug; 362(9385):677-8. PubMed ID: 12957087
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in the hormonal treatment of breast cancer.
    Boughey JC; Buzdar AU; Hunt KK
    Curr Probl Surg; 2008 Jan; 45(1):13-55. PubMed ID: 18206436
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant taxanes in the treatment of breast cancer: no longer at the tip of the iceberg.
    Dang C; Hudis C
    Clin Breast Cancer; 2006 Apr; 7(1):51-8. PubMed ID: 16764744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dense chemotherapy for primary breast cancer.
    Kümmel S; Rezai M; Kimmig R; Schmid P
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):75-81. PubMed ID: 17218856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Chemotherapy: the example of clinical studies].
    Sdrobolini A
    Suppl Tumori; 2004; 3(4):S77-8. PubMed ID: 15206220
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there a standard type and duration of adjuvant chemotherapy for early stage breast cancer?
    Hayes DF
    Breast; 2009 Oct; 18 Suppl 3():S131-4. PubMed ID: 19914531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer.
    Benson JR
    J Clin Oncol; 2005 Sep; 23(27):6807-9. PubMed ID: 16170197
    [No Abstract]   [Full Text] [Related]  

  • 8. Discouraging news for high-dose chemotherapy in high-risk breast cancer.
    Pusztai L; Hortobagyi GN
    Lancet; 1998 Aug; 352(9127):501-2. PubMed ID: 9716049
    [No Abstract]   [Full Text] [Related]  

  • 9. Current status of dose-dense chemotherapy for breast cancer.
    Seidman AD
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():78-83. PubMed ID: 16273358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of cytostatic drug dose in adjuvant chemotherapy of breast carcinoma].
    Thomssen C
    Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):M102-5. PubMed ID: 8964443
    [No Abstract]   [Full Text] [Related]  

  • 11. [San Antonio Breast Cancer Symposium 2003. New therapeutic prospects in the treatment of early-stage breast cancer].
    Montemurro F
    Tumori; 2004; 90(1):suppl 1-16. PubMed ID: 15143995
    [No Abstract]   [Full Text] [Related]  

  • 12. Extended adjuvant chemotherapy in endocrine non-responsive disease.
    Colleoni M; Munzone E
    Breast; 2013 Aug; 22 Suppl 2():S161-4. PubMed ID: 24074780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant use of taxanes for patients with breast cancer: we see the tip of the iceberg.
    Hudis C
    Clin Breast Cancer; 2002 Dec; 3(5):326-32. PubMed ID: 12533262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant clodronate in breast cancer.
    Paterson AH
    Acta Oncol; 2005; 44(1):80-2; author reply 83-4. PubMed ID: 15848910
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.
    Köstler WJ; Brodowicz T; Zielinski CC;
    J Natl Cancer Inst; 2010 Feb; 102(3):207; author reply 207-8. PubMed ID: 20054016
    [No Abstract]   [Full Text] [Related]  

  • 16. Management recommendations for adjuvant systemic breast cancer therapy.
    Perez EA
    Breast Dis; 2004; 21():15-21. PubMed ID: 15687718
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose density in breast cancer: a simple message?
    Lin NU; Gelman R; Winer EP
    J Natl Cancer Inst; 2005 Dec; 97(23):1712-4. PubMed ID: 16333021
    [No Abstract]   [Full Text] [Related]  

  • 18. New approaches to adjuvant chemotherapy for breast cancer.
    Hudis C
    Pharmacotherapy; 1996; 16(3 Pt 2):88S-93S. PubMed ID: 8726587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Breast cancer: adjuvant therapy with trastuzumab: herceptin adjuvant (HERA) Trial Study, B-31- and N9831-Study].
    Mallmann P
    Internist (Berl); 2006 Nov; 47(11):1183-5. PubMed ID: 17048017
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary chemotherapy in breast cancer.
    Smith IE; al-Moundhri M
    Biomed Pharmacother; 1998; 52(3):116-21. PubMed ID: 9755804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.